Follow Chr. Hansen A/S

Press Releases View all 5 hits

Chr. Hansen enters first collaboration on production of a next generation probiotic from the Human Microbiome

Chr. Hansen enters first collaboration on production of a next generation probiotic from the Human Microbiome

Press Releases   •   Jan 14, 2016 07:08 GMT

Today, Chr. Hansen and Caelus Health announce their collaboration on the development of Eubacterium hallii as a next generation probiotic for prevention and treatment of metabolic disease.

One of the world's largest clinical studies on probiotics reinforces significant gastrointestinal benefits of the probiotic strain named BB-12®

One of the world's largest clinical studies on probiotics reinforces significant gastrointestinal benefits of the probiotic strain named BB-12®

Press Releases   •   Sep 25, 2015 10:39 GMT

Millions of people around the world suffer from a range of gastrointestinal symptoms. Results from one of the world’s largest clinical studies on probiotics now show that the probiotic strain named BB-12® can be part of the solution by improving bowel regularity.

Chr. Hansen develops game-changing fermentation process for carmine

Chr. Hansen develops game-changing fermentation process for carmine

Press Releases   •   Jun 18, 2015 07:07 GMT

In collaboration with University of Copenhagen, Department of Plant and Environmental Sciences (KU) and Technical University of Denmark, Department of Systems Biology (DTU), researchers from Chr. Hansen have succeeded in producing carmine by a modern fermentation process. The first of a series of patents that protects the technology has been published today.

New clinical study indicates: probiotics may shorten duration of common cold and lower use of health care resources

New clinical study indicates: probiotics may shorten duration of common cold and lower use of health care resources

Press Releases   •   May 21, 2015 06:57 GMT

With the completion and publication of the world’s largest clinical study on the immune effect of probiotics in adults, Chr. Hansen has obtained results indicating that the probiotic strain named L. CASEI 431® can shorten the duration of common cold and influenza-like illness, lower the use of health care resources and reduce use of antibiotics.

Images 4 hits

Caelus logo

Caelus logo

License Creative Commons Attribution
Download
Size

113 KB • 1193 x 1224 px

Chr. Hansen probiotic strain BB-12®

Chr. Hansen probiotic str...

License Creative Commons Attribution
Download
Size

6.6 MB • 3400 x 5100 px

The natural color carmine

The natural color carmine

License Creative Commons Attribution
Download
Size

2.44 MB • 3008 x 2000 px

Infant formula

Infant formula

License Media Use
Download
Size

9.71 MB • 5760 x 3840 px

Documents 2 hits

L. CASEI 431® Selected summaries

L. CASEI 431® Selected summaries

Documents   •   May 21, 2015 06:57 GMT

This binder provides you with summaries of selected publications on Lactobacillus paracasei subsp. paracasei L. casei 431®.

L. CASEI 431® Handout

L. CASEI 431® Handout

Documents   •   May 21, 2015 06:57 GMT

Chr. Hansen offers multiple application forms of one of our most clinically documented Probio-Tec® strains, Lactobacillus L. casei 431®.